GPER1 and neoplasm: Estrogen stimulation of GPER has been further shown to activate the ERK and PI3K pathways in a matrix metalloproteinase (MMP) and EGFR dependent fashion in vitro, and GPER antagonism has been shown to block estrogen-stimulated tumor growth in vivo (20).